Lack of germline CDK6 mutations in familial melanoma

Citation
Mg. Shennan et al., Lack of germline CDK6 mutations in familial melanoma, ONCOGENE, 19(14), 2000, pp. 1849-1852
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
19
Issue
14
Year of publication
2000
Pages
1849 - 1852
Database
ISI
SICI code
0950-9232(20000330)19:14<1849:LOGCMI>2.0.ZU;2-W
Abstract
Germline mutations in genes encoding several components of the retinoblasto ma pathway have been linked with inherited predisposition to melanoma, Most commonly, such mutations involve CDKN2A, a cyclin-dependant kinase inhibit or of two kinases, CDK4 and CDK6, which phosphorylate the retinoblastoma pr otein (pRB) and thereby promote passage through the G(1)/S cell-cycle restr iction point. Less frequently, germline mutations in the CDK4 gene have als o been linked with an increased risk of melanoma, Despite the sequence and functional homology between CDK4 and CDK6, the role of germline mutations i n CDK6 in melanoma predisposition is unknown. We detected no CDK6 mutations within the p16 (CDKN2A) binding domain in index cases from 60 melanoma-pro ne kindreds that lacked germline mutations in the coding regions of either CDKN2A or within the entire CDK4 coding region. We conclude that germline m utations in CDK6 do not make a significant contribution to melanoma predisp osition.